Trials / Completed
CompletedNCT05155007
A Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on Rilematovir
A Phase 1, Open-label Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on the Single-dose Pharmacokinetics of Rilematovir
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Janssen Research & Development, LLC · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the pharmacokinetic (PK) of a single-dose of rilematovir co-administered with a single-dose of ciclosporin compared to a single-dose administration of rilematovir alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rilematovir | Rilematovir will be administered orally as per assigned treatment sequence. |
| DRUG | Ciclosporin | Ciclosporin will be administered orally as per assigned treatment sequence. |
Timeline
- Start date
- 2021-12-10
- Primary completion
- 2022-02-04
- Completion
- 2022-02-04
- First posted
- 2021-12-13
- Last updated
- 2025-02-03
Locations
1 site across 1 country: Belgium
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05155007. Inclusion in this directory is not an endorsement.